A/H5N1 Inactivated, split virion pandemic influenza vaccine

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

InfluenzaInfluenza A Virus InfectionOrthomyxoviridae InfectionsOrthomyxovirus Infections

Phase 2

Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children

CompletedNCT00491985

Sanofi Pasteur, a Sanofi CompanyInfluenza, Influenza A Virus Infection, Orthomyxoviridae Infections

Start: 2007-06-30End: 2010-06-30Updated: 2014-01-14

Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children

CompletedNCT00884182

Sanofi Pasteur, a Sanofi CompanyInfluenza, Orthomyxoviridae Infections, Orthomyxovirus Infections

Start: 2009-04-30End: 2010-06-30Updated: 2014-01-14